Contrary to exhibiting anti-tumour actions and attenuating angiogenesis, CXCL10 also has tumour-promoting ability and has been associated with advanced human cancers, in particularly in breast cancer progression and metastasis [34–37], but also in PDAC [13, 29]. The gene discussed is CXCL10; the disease is cancer.